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Regional lymph node metastasis is a very important prognostic indicator. In the metastatic process, reduction in cell to cell adhesion
including E-cadherin–catenin cell adhesion complex is an essential step. We investigated immunohistochemical expression of E-
cadherin, a-catenin and b-catenin in 159 tissue samples from patients with oral squamous cell carcinoma and examined the
correlation between their expressions and the presence of regional lymph node metastasis. Significantly greater reduction in
expression levels of E-cadherin, a-catenin and b-catenin was found in the metastatic group (n¼64) compared to the nonmetastatic
group (n¼95) (P¼0.007, 0.001, 0.001, respectively). However, there was no significant correlation between their expressions and
the features of the regional metastasis, the number of metastatic lymph nodes or the presence of extracapsular metastasis. These
data suggest that evaluation of the immunohistochemical expression of E-cadherin, a-catenin and b-catenin is extremely valuable for
the diagnosis of metastatic occurrence.
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Among oral malignancies, squamous cell carcinoma is the most
frequent and a number of studies have been conducted on the
relationship between its clinical and pathological findings in order
to improve the accuracy of prognosis for patients with this disease.
We have already reported that a significantly reduced 5-year
cumulative survival rate was observed in patients with oral
squamous cell carcinoma and lymph node metastasis as compared
with those without metastasis (Tanaka et al, 2001) and Jones et al
(1993) also emphasised that lymph node metastasis is the most
important prognostic indicator. As regards therapy, it is thus
extremely important to identify the tumours that are likely to
develop lymph node metastasis.
For metastasis to occur, cancer cells have to detach from the
primary lesion as an initial step. E-cadherin is a Ca
2þ-dependent
intercellular adhesion molecule in epithelial cells, which play an
important role in establishing and maintaining intercellular
connections and morphogenesis (Takeichi, 1991). The cytoplasmic
terminus of the E-cadherin molecule has been shown to be linked
to the actin cytoskeleton via a-catenin and b-catenin (McCrea et al,
1991; Ozawa and Kemler, 1992; Knusden et al, 1995), and E-
cadherin is directly associated with b-catenin and indirectly linked
via the a-catenin/b-catenin heterodimeric complex to a-catenin
(Alberle et al, 1994; Oyama et al, 1994; Stappert and Kemler, 1994).
It is reported that downregulation of the a-catenin, and b-catenin
seems to be associated with dysfunction of E-cadherin-mediated
cell adhesion and an increase in the metastatic potential of cancer
cells (Kadowaki et al, 1994; Matsui et al, 1994; Ochiai et al, 1994;
Pierceall et al, 1995; Rimm et al, 1995). Changes or alteration in the
function and expression of the cell to cell adhesion molecule, E-
cadherin, a-catenin and b-catenin, have been postulated to be an
early event in the multiple process of tumour metastasis and an
important factor in tumour progression (Birchmeier et al, 1993;
Ponta et al, 1994). A variety of studies regarding the relationship
between the expression of E-cadherin, a-catenin, b-catenin and the
existence of lymph node metastasis in human cancers have been
performed and some authors found a significant correlation (Sato
et al, 1999; Zheng et al, 1999), while others did not (Mattijssen et al,
1993; Andrews et al, 1997).
This study was performed to clarify whether the expression of E-
cadherin, a-catenin and b-catenin was correlated with the
existence of lymph node metastasis in 159 patients with oral
squamous cell carcinoma. To the best of our knowledge, this study
is the first report that has examined the effect of altered expression
of these proteins on regional metastasis in oral squamous cell
carcinoma.
MATERIALS AND METHODS
Samples
We obtained 159 primary tumour samples, at the time of either
biopsy for initial diagnosis or surgical resection, from 159 patients
with oral squamous cell carcinoma consisting of 84 cases of
carcinoma of the tongue, seven of the upper gingiva, 26 of the
lower gingiva, 27 of the floor of the mouth, 13 of the buccal mucosa
and two cases of carcinoma of the lip. The patients were treated at
the Department of Oral Surgery, Sapporo Medical University
School of Medicine. The treatment modality employed was surgery
under snap-frozen section control or induction chemotherapy
followed by definitive surgery. None of the samples examined was
influenced by chemotherapeutic agents because in the cases in Revised 24 March 2003; accepted 7 May 2003
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before the chemotherapy. The age of the patients ranged from 26 to
85 years (average, 59.0 years). There were 55 male and 104 female
patients. The grade of histological differentiation was determined
following WHO 1997 criteria. The mode of invasion at the
tumour–host borderline was classified into three types (expansive,
moderately invasive and markedly invasive), with a modification
of criteria used by Umeda et al (1992). Briefly, the expansive type
had a well-defined borderline, the moderately invasive type
exhibited no distinct borderline and had parenchyma consisting
of large tumour cell nests and the markedly invasive type spread in
small aggregates with ramifications or invaded diffusely without
forming nests of tumour cells. We divided the samples into two
groups: (1) pN( ) group (n¼95): cervical lymph node metastasis
was not recognised clinicopathologically for at least 2 years after
surgery, (2) pN(þ) group (n¼64): cervical lymph node was
recognised. Among the pN(þ) group, radical neck dissection was
performed in 30 cases, functional neck dissection in 22 cases and
supraomohyoid neck dissection was performed in 12 cases.
Immunohistochemistry
The tissue samples obtained were fixed in 10% buffered formalin
and embedded in paraffin. Paraffin sections (6mm) were made,
dewaxed, hydrated and immersed in citrate buffer (0.001 M citric
acid, pH 6.0) for 5min in an autoclave (1211C) for antigen
retrieval. The sections were rinsed with 0.001 M phosphate-buffered
saline (PBS) three times for 5min each time, and then immersed in
0.3% hydrogen peroxide containing methanol to inactive endo-
genous peroxidase, and to block for nonstaining in normal goat
serum in PBS for 30min at room temperature. The sections were
then incubated with primary antibody (anti-E-cadherin dilution
with 1:100 (clone 36, Transduction Laboratories, Kentucky, USA)
anti-a-catenin dilution with 1:100 (clone 5, Transduction Labora-
tories, Kentucky, USA) and anti-b-catenin dilution with 1:100
(clone 14, Transduction Laboratories, Kentucky, USA)) overnight
at 41C, rinsed with PBS three times for 5min each time, and
incubated with the secondary antibody, biotinylated goat anti-
mouse immunoglobulin (IgG) (SC-2039; Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) for 30min at room temperature and then
rinsed again as previously described. The sections were finally
incubated in avidin–biotin complex (Vector Laboratories, Burlin-
game, CA, USA) for 60min at room temperature, then rinsed again
as previously described. Visualisation of the peroxidase was
performed using diaminobenzine in PBS with 0.005% hydrogen
peroxide for 5min. The sections were counterstained with
haematoxylin, dehydrated and mounted. In each experiment,
primary monoclonal antibodies were replaced with PBS in
duplicate sections for negative controls.
Evaluation of E-cadherin and catenins expression
All sections were examined by three independent pathologists who
were blinded to the patients’ clinical information, using a slight
modification of the scoring method described previously (Andrews
et al, 1997), and the staining pattern was evaluated semiquantita-
tively by comparing the intensity and cellular localisation of
immunostaining with those of the adjacent normal epithelium as
an internal positive control. If immunoreaction was uniformly
membraneous and strong, similar to that in the internal controls,
the staining was defined as normal. When immunoreaction was
negative or weak, with either heterogeneous (mixed areas of
positive and negative cells with normal membraneous staining)
and/or altered cellular distribution (cytoplasmic and/or nuclear
staining in more than 20% of the tumour cells, regardless of
membraneous staining) of immunostaining, the staining was
classified as abnormal. For each molecule, levels of immunoreac-
tion were graded according to whether more than 75, 25–75 or less
than 25% of cells showed the normal pattern of strong
membraneous staining. For practical and statistical purposes, the
immunoreactions in more than 75% and in less than 75% were also
estimated as preserved and reduced, respectively. In tumours
showing heterogeneity of staining, the immunostaining of the
tumour was judged according to the prominent pattern. For each
section, at least 500 cells, and usually more than 1000 tumour cells
were analysed in 10 random high power fields ( 400). Whenever
there were some discrepancies in the evaluation between
observers, a consensus was reached using a multiheaded micro-
scope. Cases in which internal positive control failed to show clear
staining were excluded from this study.
Statistical analysis
All statistical analyses were performed using SPSS 10.0J for
Windows. The association between the presence of regional
metastasis and clinicopathological variables was analysed using
w
2 tests and Fishers exact tests. P-values o0.05 were considered to
be statistically significant. Differences in survival analysed by the
Kaplan–Meier method were assessed by the log-rank test.
RESULTS
Cytomembraneous expressions of E-cadherin, a-catenin and b-
catenin were observed from the basal layer to the spinosum layer
of normal oral epithelia and lost in the superficial layer (Figure 1).
Figure 1 E-cadherin expression in normal oral epithelium. (A) Negative
control, original magnification  170; (B) E-cadherin is detected mainly on
the cell membrane of the basal layer to the spinosum layer, original
magnification  170.
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cytomembrane, or both in the cytoplasm and the nucleus.
Representative immunohistochemical stainings of these molecules
are shown in Figures 2–4.
The expressions of E-cadherin, a-catenin and b-catenin are
summarised in Table 1. Out of the total 159 cases, reduced
expression of E-cadherin, a-catenin and b-catenin was found in 92
(57.9%), 115 (72.3%) and 114 (71.7%), respectively.
Association between expression of E-cadherin, a-catenin,
and b-catenin and existence of lymph node metastasis
(Table 1)
There was no significant association between age, gender, site of
tumour or histological differentiation and the existence of lymph
node metastasis in patients with oral squamous cell carcinoma.
Lymph node metastasis was found more frequently in the cases
with T3 or T4 tumour than in those with T1 or T2 tumour
(P¼0.001), and there was a significant association between a high
grade of mode of carcinoma invasion of primary tumours and
lymph node metastasis (P¼0.004).
Reduced E-cadherin expression was observed in 48 out of the 95
pN( ) cases, while it was seen in 44 out of the 64 pN(þ) cases.
There was a significant association between reduction of E-
cadherin in primary tumours and lymph node metastasis
(P¼0.007). As well as E-cadherin, the expressions of a-catenin
and b-catenin were also significantly reduced in pN(þ) cases as
compared with in pN( ) cases (P¼0.001, o0.001, respectively).
Association between expression of E-cadherin, a-catenin
and b-catenin and features of lymph node metastasis
(Table 2)
We were able to investigate the features of lymph node metastasis,
such as the number of metastatic lymph nodes (below two vs over
three) and the existence of extracapsular metastatic lymph node in
53 pN(þ) cases. We investigated the correlation between the
expression of E-cadherin, a-catenin and b-catenin, mode of
carcinoma invasion, degree of differentiation, site of the tumour,
and tumour size and the features of metastatic lymph node;
however, no significant association was recognised.
Association between expression of E-cadherin, a-catenin,
b-catenin and clinicopathological features (Table 3)
The expression of E-cadherin did not appear to differ significantly
based on tumour size or the degree of differentiation of the
primary tumour. The reduced expression of E-cadherin was found
to be related to the grade of carcinoma invasion (P¼0.033),
meaning that the reduced expression was more frequently found in
the tumours with a high grade of mode of carcinoma invasion than
in tumours with a low grade of mode of invasion.
The same investigation was performed for a-catenin and
b-catenin. There were significant associations between the
Figure 2 E-cadherin expression in oral squamous cell carcinoma. (A)A n
oral squamous cell carcinoma shows preserved E-cadherin expression,
original magnification  170; (B) An oral squamous cell carcinoma shows
reduced E-cadherin expression, original magnification  170.
Figure 3 a-catenin expression in oral squamous cell carcinoma. (A)A n
oral squamous cell carcinoma shows preserved a-catenin expression,
original magnification  170; (B) An oral squamous cell carcinoma shows
reduced a-catenin expression, original magnification  170.
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of the primary tumour (P¼0.018, 0.007, respectively), meaning that
the expressions of a-catenin and b-catenins were reduced in many of
the cases with a high grade of mode of carcinoma invasion.
Association between expression of E-cadherin, a-catenin,
and b-catenin and survival of patients with oral squamous
cell carcinoma (Figure 5)
Survival in patients showing reduced expressions of E-cadherin, a-
catenin and b-catenin was significantly shorter than in patients
showing preserved expressions (P¼0.0306, 0.0033, 0.0004, respec-
tively).
DISCUSSION
The incidence of neck metastasis in oral squamous cell carcinoma
is relatively high (Lee and Krause, 1975, Martis et al, 1979).
The T classification of oral squamous cell carcinoma was
correlated with the incidence of neck metastasis in the current
study, which was consistent with the previous reports (Moore et al,
1986a, Mendenhall et al, 1988).
Moore et al (1986b) noted that tumour thickness was an
accurate predictor of lymph node metastasis; however, its
usefulness might be limited because measurement requires
resection of the lesion.
The current study dealt with 159 oral squamous cell carcinomas,
which is the largest series reporting the correlation between the
expression of the E-cadherin-associated molecules and the
presence of neck metastasis and it showed a significant correlation
between them, indicating that the reduced expression of E-
cadherin is a key function in the increased incidence of neck
metastasis. Bukholm et al (1998) reported that there was no
significant difference between the expression of E-cadherin and the
presence of regional metastasis in human breast cancer, and it is
said that the significance of changes in the E-cadherin complex
may vary from tumour to tumour (Kinsella et al, 1993).
In the present study, there was a significant correlation between
the expression of a-catenin or b-catenin and the presence of neck
metastasis. It is reported that a significant association was seen
between reduction in immunoreactivity of at least one of the
following proteins: E-cadherin, a-catenin, b-catenin and g-catenin
and the presence of metastasis in breast carcinoma (Bukholm et al,
1998). Gofuku et al (1999) stated that reduction of a-catenin was a
Figure 4 b-catenin expression in oral squamous cell carcinoma. (A)A n
oral squamous cell carcinoma shows preserved b-catenin expression,
original magnification  170; (B) An oral squamous cell carcinoma shows
reduced b-catenin expression, original magnification  170.
Table 1 Correlation of regional metastasis and clinicopathological
findings in 159 patients with oral squamous cell carcinoma
Clinicopathological feature pN( ) pN(+)
Age (years)
o50 18 11 P¼0.914
50–69 61 44 w
2¼0.830
469 16 9
Gender
Male 38 17 P¼0.057
Female 57 47 w
2¼0.081
Tumour site
Tongue 56 28 P¼0.058
Upper gingiva 6 1 w
2¼0.016
Lower gingiva 16 10
Floor of mouth 8 19
Buccal mucosa 8 5
Lip 1 1
Tumor size
T1&T2 84 43 P¼0.001
T3&T4 11 21 w
2¼0.001
Differentiation
Well 52 32 P¼0.190
Moderate 36 21 w
2¼0.158
Poor 7 11
Mode of invasion
Expansive 20 5 P¼0.004
Moderately invasive 50 30 w
2¼0.014
Markedly invasive 25 29
E-cadherin
475% 47 20 P¼0.007
25–75% 32 23 w
2¼0.027
o25% 16 21
a-Catenin
475% 35 9 P¼0.001
25–75% 37 27 w
2¼0.003
o25% 23 28
b-Catenin
475% 38 7 Po0.001
25–75% 33 27 w
2¼0.000
o25% 24 30
Total 95 64
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cadherin in evaluating the potential for tumour invasion and
metastasis in human colorectal cancer. However, the mechanism of
E-cadherin-mediated intercellular adhesion is not fully understood
yet and further study is needed in order to clarify which protein
expression among E-cadherin, a-catenin, and b-catenin is most
useful for diagnosis and prediction of metastasis and tumour
invasion.
We performed a clinical examination of oral squamous cell
carcinoma cases which received neck dissection and the results
Table 2 Correlation of clinicopathological findings and features of regional metastasis
Number of metastatic lymph nodes Character of metastatic lymph nodes
Clinicopathological feature Below two Over three Extracapsular Intracapusular
Tumour site
Tongue 21 6 P¼0.166 11 16 P¼0.680
Gingiva 5 5 5 5
Floor of mouth 7 6 5 8
Buccal mucosa 2 1 2 1
Tumour size
T1 and T2 22 9 P¼0.272 11 20 P¼0.136
T3 and T4 13 9 12 10
Differentiation
Well 14 10 P¼0.331 10 14 P¼0.288
Moderate 15 4 12 7
Poor 6 4 1 9
Mode of invasion
Expansive 4 1 P¼0.692 3 2 P¼0.083
Moderately invasive 16 9 14 11
Markedly invasive 15 8 6 17
E-cadherin
475% 8 3 P¼0.633 7 4 P¼0.085
25–75% 13 7 9 11
o25% 14 8 7 15
a-Catenin
475% 4 2 P¼0.806 4 2 P¼0.420
25–75% 17 8 10 15
o25% 14 8 9 13
b-Catenin
475% 2 1 P¼0.383 2 1 P¼0.559
25–75% 12 9 9 12
o25% 21 8 12 17
Total 35 18 23 30
Table 3 Correlation of the expression of E-cadherin, a-catenin, b-catenin and clinicopathological findings
E-cadherin a-catenin b-catenin
Clinicopathological feature 475% 25–75% o25% 475% 25–75% o25% 475% 25–75% o25%
Tumour size
T1 and T2 57 40 30 P¼0.446 39 46 42 P¼0.508 40 44 43 P¼0.294
T3 and T4 10 15 7 w
2¼0.234 5 18 9 w
2¼0.089 5 16 11 w
2¼0.144
Differentiation
Well 40 27 17 P¼0.090 25 34 25 P¼0.377 29 25 30 P¼0.487
Moderate 21 23 13 w
2¼0.346 14 25 18 w
2¼0.696 12 27 18 w
2¼0.227
Poor 6 5 7 5 5 8 4 8 6
Mode of invasion
Expansive 15 8 2 P¼0.033 10 9 6 P¼0.018 12 11 2 P¼0.007
Moderately invasive 34 25 21 w
2¼0.149 23 36 21 w
2¼0.122 24 23 33 w
2¼0.003
Markedly invasive 18 22 14 11 19 24 9 26 19
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metastatic lymph nodes and/or extracapsular metastatic lesion
were poor. Therefore, we investigated the correlation between the
expression of E-cadherin, a-catenin and b-catenin and the
presence of three or more metastatic lymph nodes and/or
extracapsular metastatic lesions. However, there were no correla-
tions between them. We reported that from ultrastuctural
observation of primary and metastatic oral squamous cell
carcinomas, morphologic similarity was recognised between the
primary and metastatic lesions; however, the features of junctional
complexes varied from the primary lesion to the metastatic
one in some cases (Tanaka et al, 2002). Whether regional
metastasis occurs or not may depend on the features of the
primary lesion, including the intercellular adhesion of the tumour
cells. However, the features of the metastatic lesion may
be independent of those of the primary lesion and may be
mainly influenced by circumustances unique to the metastatic
lesion itself.
Mode of carcinoma invasion evaluated from the biopsied
specimens has already been reported to be related to regional
metastasis (Yamamoto et al, 1984), which is consistent with the
result of the current study. Tumour invasion is also related to
intercellular adhesion and there were also correlations between the
mode of carcinoma invasion and the expressions of E-cadherin, a-
catenin and b-catenin.
The T classification correlated with the presence of neck
metastasis, however not with the expression of E-cadherin, a-
catenin or b-catenin. Growth of the tumour may correlate not only
with intercellular adhesion but also with other factors.
The correlation between mutation or methylation of E-cadherin,
a-catenin or b-catenin and the presence of metastasis is now under
investigation in order to clarify the mechanism of metastasis (Ogi
et al, 2002).
In conclusion, in the cases with oral squamous cell carcinoma
that develop regional metastasis, the expression of E-cadherin, a-
catenin and b-catenin was reduced and therefore it is strongly
suggested that immunohistochemical investigation of these
proteins is presently of value for the purpose of diagnosing the
presence of metastasis.
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Figure 5 The Five-year cumulative survival rate (Kaplan–Meier). The 5-
year cumulative survival rate of the patients with reduced expressions of E-
cadherin or a-catenin or b-catenin tumours is significantly lower than that
with preserved expressions of E-cadherin or a-catenin or b-catenin ones.
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